Patient Management

2074 soru

Soru 701Soru →

A 68-year-old man is evaluated in the intensive care unit for sudden-onset shortness of breath and right-sided pleuritic chest pain. Three days ago, he underwent a left frontotemporal craniotomy for resection of a glioblastoma. His temperature is 37.1°C (98.8°F), blood pressure is 118/76 mm Hg, pulse is 112/min, and respirations are 24/min. Pulse oximetry shows 91% on room air. Physical examination reveals a well-healing cranial incision. The lungs are clear to auscultation bilaterally. Laboratory studies show a troponin I level of 0.8 ng/mL (normal: <0.04<0.04 ng/mL). A computed tomography pulmonary angiogram demonstrates a large filling defect in the right main pulmonary artery with associated right ventricular enlargement. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Placement of an inferior vena cava filter

Cevap

Placement of an inferior vena cava filter is the most appropriate next step for this patient, as it prevents further embolization in the setting of an absolute contraindication to therapeutic anticoagulation.
The correct answer is placement of an inferior vena cava (IVC) filter. This patient has an acute submassive pulmonary embolism (PE), as indicated by the computed tomography (CT) findings, right ventricular enlargement, and elevated troponin level. The standard first-line treatment for a submassive PE is therapeutic anticoagulation (e.g., intravenous heparin). However, this patient underwent a craniotomy 3 days ago. Recent intracranial surgery (typically within the past 2 to 3 weeks) is an absolute contraindication to therapeutic anticoagulation due to the prohibitive risk of fatal intracranial hemorrhage. When a patient has an acute venous thromboembolism and an absolute contraindication to anticoagulation, a surgical or procedural intervention is required to prevent further embolization. Placement of an IVC filter traps large emboli originating from the deep veins of the lower extremities and pelvis, effectively preventing them from reaching the pulmonary circulation while the patient recovers from surgery.

Adım Adım Çözüm

1
Identify the primary diagnosis and establish the risk stratification.
The patient has an acute submassive (intermediate-risk) pulmonary embolism, evidenced by the filling defect on CT angiography, right ventricular enlargement, and an elevated troponin level.
Risk stratification dictates whether the patient requires standard anticoagulation, advanced therapies like thrombolysis, or surgical interventions.
2
Evaluate the patient's medical history for contraindications to standard pharmacologic therapy.
The patient underwent a craniotomy 3 days ago. This is an absolute contraindication to both therapeutic anticoagulation (e.g., heparin) and thrombolysis.
Administering standard-of-care anticoagulants in the immediate postoperative period of a neurosurgical procedure carries a prohibitive risk of fatal intracranial hemorrhage.
3
Determine the most appropriate alternative procedural intervention.
Placement of an inferior vena cava (IVC) filter is required.
When anticoagulation is absolutely contraindicated, an IVC filter must be placed to mechanically trap deep vein thrombi from the lower extremities before they can reach the pulmonary circulation.

Anahtar Kavram

In patients with acute venous thromboembolism who have an absolute contraindication to therapeutic anticoagulation (such as recent intracranial surgery), the placement of an inferior vena cava filter is the most appropriate next step in management.
Soru 702Soru →

A 34-year-old woman presents to the clinic for a routine health maintenance visit. Six months ago, she was diagnosed with Crohn disease involving the terminal ileum and colon. Her disease is currently in clinical remission on a maintenance regimen of infliximab and azathioprine. She feels well and reports no abdominal pain, diarrhea, or weight loss. She works as a high school teacher. Review of her immunization records reveals she received all standard childhood vaccines but has not received any immunizations since age 18. Laboratory evaluation shows negative varicella-zoster virus IgG antibodies. Her vital signs and physical examination today are unremarkable. Which of the following is the most appropriate next step in the preventive management of this patient?

Cevabı ve açıklamayı göster

Cevap: Administer the 20-valent pneumococcal conjugate vaccine

Cevap

Administer the 20-valent pneumococcal conjugate vaccine
The correct intervention is to administer the 20-valent pneumococcal conjugate vaccine. Patients receiving immunosuppressive medications, such as the tumor necrosis factor (TNF) inhibitor infliximab and the antimetabolite azathioprine, have an acquired immunodeficiency. This places them at a significantly increased risk for severe, invasive pneumococcal disease. Current guidelines explicitly recommend pneumococcal vaccination for adults aged 19 to 64 years with immunocompromising conditions. Because the pneumococcal conjugate vaccine is an inactivated (non-live) vaccine, it is safe to administer while the patient is actively taking these medications and will provide crucial protection.

Adım Adım Çözüm

1
Identify the patient's immune status based on her medication history.
The patient is actively taking infliximab and azathioprine, which means she is significantly immunocompromised.
Immune status dictates both the indications for specific vaccines (e.g., pneumococcal) and the absolute contraindications (e.g., live-attenuated vaccines).
2
Determine the indication for pneumococcal vaccination.
Pneumococcal vaccination is indicated.
Guidelines recommend pneumococcal vaccination for all adults aged 19 to 64 years with immunocompromising conditions, including iatrogenic immunosuppression.
3
Evaluate the safety of the proposed interventions.
The 20-valent pneumococcal conjugate vaccine is an inactivated vaccine and is safe to administer. The varicella vaccine is a live vaccine and is strictly contraindicated.
Live-attenuated vaccines can cause uncontrolled viral replication and disseminated disease in immunocompromised hosts.

Anahtar Kavram

Inactivated vaccines (e.g., pneumococcal conjugate) are indicated and safe for immunocompromised patients, whereas live-attenuated vaccines (e.g., varicella) are absolutely contraindicated.
Soru 703Soru →

A 42-year-old man is being prepared for discharge after a 28-day hospital course for severe acute necrotizing pancreatitis complicated by infected pseudocysts. He underwent multiple exploratory laparotomies and abdominal washouts. He is now afebrile, tolerating a transitional oral diet, and his open abdominal wounds are healing well via secondary intention, though they require daily complex dressing changes. The multidisciplinary team determines he is stable to be discharged to his private residence with support from a Home Health Agency (HHA) for wound care and outpatient parenteral antimicrobial therapy (OPAT).

Arrange the following steps of the hospital discharge and care transition process in the most appropriate chronological sequence to ensure patient safety and minimize the risk of readmission.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence begins with documenting clinical stability and generating the referral, followed by completing medication reconciliation, coordinating medical supplies, providing patient/family education, and finally executing the clinician-to-clinician handoff.
According to established transitions of care protocols (e.g., Project BOOST, IDEAL discharge planning), a safe and effective discharge requires a strict logical progression. The destination must be determined first. Then, the clinical plan (medication reconciliation) must be finalized. Once the clinical requirements are known, the physical logistics (supplies, equipment) can be procured. With the complete clinical and logistical plan synthesized, the patient and family can be properly educated. Finally, once the plan is fully enacted and understood by the patient, the comprehensive data is handed off to the receiving clinical team.

Adım Adım Çözüm

1
Determine and document clinical stability for the specific post-acute setting.
The target disposition (home with HHA) is formally established.
The discharge destination dictates all subsequent requirements, including the scope of the referral and the required resources.
2
Perform comprehensive medication reconciliation.
The post-discharge medication list, including the complex OPAT regimen, is finalized.
The finalized medication and treatment regimen is the core clinical component upon which logistics and education are built.
3
Coordinate procurement of durable medical equipment and wound supplies.
Logistical barriers to home care are resolved.
Specific supply needs can only be accurately ordered once the precise medical and therapeutic regimens are finalized.
4
Conduct teach-back education with the patient and family.
The patient and caregivers demonstrate understanding of the transition plan.
Effective education requires a finalized, comprehensive care plan. Conducting this before logistics are confirmed can lead to confusing or contradictory instructions.
5
Transmit the discharge summary and perform a clinician verbal handoff.
The receiving facility assumes care with complete information.
The handoff must encompass the entirely finalized plan, including patient understanding and confirmed logistics, to prevent immediate post-discharge adverse events.

Anahtar Kavram

Safe Care Transitions and Hospital Discharge Sequencing
Soru 704Soru →

An internal medicine physician is coordinating the care transition for a 69-year-old woman on hospital day 6. She was initially hospitalized for sepsis secondary to a complicated urinary tract infection. Her clinical course included a three-day intensive care unit stay requiring vasopressor support. She has since been successfully stepped down to the general medical floor, and her infection has clinically resolved on targeted oral antibiotic therapy. She has a history of diet-controlled type 2 diabetes mellitus and moderate osteoarthritis of the knees.

Her vital signs are now stable and within normal limits. A multidisciplinary evaluation notes that she requires moderate physical assistance from one person to transfer from a bed to a chair and to walk short distances. During daily sessions with physical and occupational therapy, the patient becomes visibly exhausted and cannot participate in therapeutic exercises for more than 45 minutes total per day.

Before her illness, she lived independently in a single-story house. Her only relative is a son who lives in a neighboring state and is unable to provide physical assistance or stay with her.

Based on her clinical and functional status, which of the following is the most appropriate next step in care transition for this patient?

Cevabı ve açıklamayı göster

Cevap: Transfer to a skilled nursing facility

Cevap

Transfer to a skilled nursing facility
The correct answer is a transition to a skilled nursing facility (SNF). This patient has experienced significant hospital-associated deconditioning following a severe illness and an ICU stay. Although she is medically ready for discharge from the acute care hospital, her new inability to transfer or ambulate independently makes a direct discharge home unsafe, particularly since she lives alone without an available caregiver. Home health services are inadequate because they provide only intermittent visits, leaving her without physical assistance for basic daily mobility needs for the majority of the time. Furthermore, she cannot be transferred to an inpatient rehabilitation facility (IRF) because standard clinical criteria and Medicare guidelines require IRF patients to tolerate at least 3 hours of intensive therapy per day. Since she becomes exhausted after just 45 minutes, an SNF is the safest and most appropriate setting, offering 24-hour nursing supervision and a less intensive, slower-paced rehabilitation program tailored to her current energy levels.

Adım Adım Çözüm

1
Evaluate the patient's medical stability.
The patient's sepsis has resolved, vital signs are normal, and she is stable on oral antibiotics, indicating she no longer needs acute inpatient hospital care.
Determining medical stability is the first step in confirming readiness for discharge from the acute care hospital.
2
Assess the patient's functional capacity and therapy tolerance.
The patient requires moderate physical assistance for transfers and ambulation, and she fatigues after 45 minutes of therapy per day.
Functional status and daily therapy tolerance dictate the appropriate level of post-acute care (e.g., SNF versus IRF).
3
Analyze the patient's social support system and home environment.
The patient lives alone and her son cannot provide daily physical assistance.
The lack of a 24-hour caregiver precludes discharging a highly dependent patient directly to home, even with visiting home health services.
4
Synthesize findings to select the optimal care setting.
A skilled nursing facility (SNF) is chosen because it provides 24-hour nursing assistance and a lower-intensity rehabilitation program suited for her 45-minute tolerance.
This matches the patient's clinical needs with standard Medicare facility admission criteria and ensures patient safety.

Anahtar Kavram

Criteria for transition to post-acute care settings based on medical stability, physical therapy tolerance, and social support constraints.
Soru 705Soru →

A 78-year-old woman is evaluated on hospital day 7 for disposition planning. She was admitted for an acute right middle cerebral artery territory ischemic stroke. Her hospital course was complicated by mild aspiration pneumonia, which has been fully treated with a 5-day course of intravenous antibiotics.

Her past medical history includes hypertension, vascular dementia, and severe oropharyngeal dysphagia. A percutaneous endoscopic gastrostomy (PEG) tube was placed two years ago, and her enteral feeding regimen is well-tolerated and stable.

Currently, she is afebrile and medically stable with vital signs within normal limits. She is breathing comfortably on room air.

Neurologic examination shows dense left-sided hemiplegia, profound left-sided neglect, and expressive aphasia. She is bedbound and requires maximal assistance from two caregivers for all activities of daily living (ADLs), including bed mobility, transfers, and personal hygiene. She is unable to follow multi-step commands and cannot actively participate in physical or occupational therapy sessions.

The patient lives with her 82-year-old husband, who has advanced Parkinson disease and relies on a motorized wheelchair. He is her designated healthcare proxy and states he can no longer physically care for her at home. He is fully cooperative with the medical team's recommendations. They have no other local family support.

Which of the following is the most appropriate next step in the disposition of this patient?

Cevabı ve açıklamayı göster

Cevap: Transfer to a long-term care facility for custodial care

Cevap

Transfer to a long-term care facility for custodial care
The correct disposition is to transfer the patient to a long-term care facility for custodial care. This patient is medically stable but has profound, likely permanent neurologic deficits resulting in a total dependence for activities of daily living (ADLs). Because her husband cannot safely provide this level of physical care at home, she requires facility placement. Crucially, she does not qualify for a Skilled Nursing Facility (SNF) or an Inpatient Rehabilitation Facility (IRF) because she lacks a 'skilled need.' She has no requirement for complex daily nursing care (her PEG is chronic and stable, and her antibiotics are complete), and her cognitive and physical deficits prevent her from actively participating in a rehabilitation program. Therefore, her needs are strictly custodial (ADL assistance), which is provided in a long-term care facility setting.

Adım Adım Çözüm

1
Analyze the patient's medical stability.
The patient is afebrile, hemodynamically stable, has completed her antibiotic course, and has a stable chronic PEG tube.
Establishing medical stability rules out the need for an acute care floor or a Long-Term Acute Care Hospital (LTACH).
2
Evaluate functional capacity and rehabilitation potential.
She requires maximum assistance for all ADLs, cannot follow commands, and cannot participate in active therapy.
This determines eligibility for rehabilitation facilities. Inability to participate rules out an Inpatient Rehabilitation Facility (IRF) and skilled rehabilitation under a Skilled Nursing Facility (SNF).
3
Determine the need for daily skilled nursing care.
Her PEG tube is chronic and stable, and she has completed her IV antibiotics. She has no active skilled nursing requirements.
Lack of daily skilled nursing needs officially disqualifies her from Medicare-covered short-term SNF placement.
4
Assess the social support system.
Her husband is physically unable to provide the 24-hour total care she requires, making home discharge unsafe.
Lack of an able caregiver necessitates facility placement for 24-hour assistance.
5
Synthesize findings to select the appropriate disposition.
The patient requires a custodial care facility (long-term care facility).
She has strict custodial needs (ADL assistance only) and requires 24-hour facility supervision due to an inadequate home support structure.

Anahtar Kavram

Patients who are medically stable, lack daily skilled nursing needs, and cannot participate in rehabilitation, but require 24/7 ADL assistance, must be transitioned to a long-term care facility for custodial care, rather than a skilled nursing facility (SNF).
Tahmini Süre:1m 30s
Soru 706Soru →

A 48-year-old man presents to the primary care clinic reporting worsening fatigue, excessive sweating, and joint pain in his knees and hands over the past year. He mentions that his wedding ring no longer fits and he recently had to purchase shoes two sizes larger than his usual size. He has a history of newly diagnosed hypertension and obstructive sleep apnea. Vital signs show a blood pressure of 152/94 mm Hg, heart rate of 76/min, and respiratory rate of 14/min. Physical examination reveals coarse facial features, a prominent mandible, macroglossia, and enlarged, doughy hands. Visual field testing by confrontation is normal. A serum insulin-like growth factor-1 (IGF-1) level is ordered and returns markedly elevated for his age and sex. Which of the following is the most appropriate next step in the patient's diagnostic workup?

Cevabı ve açıklamayı göster

Cevap: Measurement of serum growth hormone following an oral glucose load

Cevap

Measurement of serum growth hormone following an oral glucose load
In the diagnostic workup of acromegaly, an elevated IGF-1 is a highly sensitive initial screening test, but the diagnosis must be definitively confirmed with an oral glucose tolerance test (OGTT). In healthy individuals, a glucose load suppresses growth hormone (GH) secretion to very low levels. In patients with acromegaly, autonomous secretion from a pituitary adenoma causes GH levels to remain elevated despite the glucose load. This biochemical confirmation is absolutely required before proceeding to structural imaging studies.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation.
The patient exhibits classic symptoms of acromegaly, including enlarging extremities, coarse facial features, macroglossia, and associated conditions like hypertension and sleep apnea.
Establishing the pre-test probability directs the appropriate diagnostic pathway.
2
Evaluate the results of the initial investigation.
The serum IGF-1 level is markedly elevated, which serves as a positive initial screening test for acromegaly.
IGF-1 provides an integrated measure of growth hormone secretion over time, making it the best initial screening test.
3
Determine the proper sequence of the diagnostic workup.
The correct algorithm for acromegaly is: Clinical suspicion → Screen (IGF-1) → Confirm (oral glucose tolerance test with GH measurement) → Localize (MRI pituitary).
Following evidence-based guidelines prevents unnecessary invasive testing, misdiagnosis from incidentalomas, and inappropriate treatments.
4
Select the next indicated step based on the algorithm.
Since the screening test (IGF-1) is positive, the next required step is the confirmatory oral glucose tolerance test.
Biochemical confirmation must be obtained before imaging the pituitary gland.

Anahtar Kavram

The diagnostic workup for acromegaly requires sequential testing: initial screening with serum IGF-1, followed by biochemical confirmation using an oral glucose tolerance test (OGTT) to demonstrate a failure of growth hormone suppression, and finally, MRI of the pituitary gland for tumor localization.
Soru 707Soru →

A 62-year-old woman presents to the outpatient clinic with a 4-day history of intense vulvar pruritus, dysuria, and a thick, white, odorless vaginal discharge. Her medical history is significant for a mechanical mitral valve replacement 5 years ago, for which she takes daily warfarin. Her other medications include metoprolol and low-dose aspirin. Her last international normalized ratio (INR) obtained one week ago was 2.8, which is within her target range of 2.5 to 3.5. Vital signs are within normal limits. Pelvic examination reveals significant vulvovaginal erythema and thick, adherent white plaques on the vaginal walls. A potassium hydroxide (KOH) preparation of the vaginal discharge reveals branching pseudohyphae and budding yeast. Which of the following is the most appropriate pharmacologic intervention for this patient?

Cevabı ve açıklamayı göster

Cevap: Intravaginal clotrimazole

Cevap

Intravaginal clotrimazole is the best choice because it provides effective local treatment for candidiasis while avoiding a dangerous systemic interaction with warfarin.
The correct answer provides a targeted, highly effective antifungal treatment for vulvovaginal candidiasis while acting purely locally. Because the patient is anticoagulated with warfarin, avoiding systemic drug interactions is critical. Warfarin's active S-enantiomer is primarily metabolized by the hepatic cytochrome P450 2C9 (CYP2C9) enzyme. Intravaginal clotrimazole has minimal to no systemic absorption and will not interfere with CYP2C9 metabolism, ensuring the patient's INR remains stable within her target range.

Adım Adım Çözüm

1
Diagnose the patient's acute presentation based on clinical and microscopic findings.
The patient has vulvovaginal candidiasis.
Intense vulvar pruritus, thick white discharge, and branching pseudohyphae with budding yeast on a KOH preparation are classic diagnostic features of a Candida infection.
2
Identify the standard first-line therapies for this condition.
Uncomplicated vulvovaginal candidiasis is typically treated with either oral fluconazole or a topical azole (e.g., intravaginal clotrimazole or miconazole).
Both modalities are highly effective and recommended by clinical guidelines for uncomplicated cases.
3
Evaluate the patient's current medication list for potential drug-drug interactions.
The patient is actively taking warfarin for a mechanical mitral valve replacement.
Prescribing systemic medications requires verifying safety against the patient's existing high-risk drug regimen.
4
Select the safest pharmacologic intervention that avoids adverse effects.
Intravaginal clotrimazole should be prescribed instead of oral fluconazole.
Oral fluconazole is a strong inhibitor of CYP2C9, the primary enzyme that metabolizes warfarin. Co-administration risks a supratherapeutic INR and fatal hemorrhage. Intravaginal clotrimazole acts locally with negligible systemic absorption, bypassing this interaction.

Anahtar Kavram

In patients taking warfarin, localized therapies (like intravaginal clotrimazole) should be prioritized over interacting systemic agents (like oral fluconazole) to treat superficial infections, thereby avoiding CYP2C9 inhibition and severe bleeding complications.
Soru 708Soru →

A 67-year-old man is evaluated in the emergency department for sudden-onset, severe, tearing pain between his shoulder blades that began two hours ago. He has a history of poorly controlled hypertension, hyperlipidemia, and a 40-pack-year smoking history. On presentation, his blood pressure is 218/114 mmHg in the right arm and 212/110 mmHg in the left arm, and his heart rate is 112/min. Physical examination reveals a distressed, diaphoretic patient. Cardiovascular examination shows a regular rhythm with no murmurs. Abdominal examination reveals diffuse tenderness with voluntary guarding and diminished bowel sounds. The right lower extremity is cool to the touch with absent dorsalis pedis and posterior tibial pulses; left lower extremity pulses are normal. Initial laboratory studies show a serum lactate level of 5.8 mmol/L and a serum creatinine of 2.1 mg/dL (baseline 1.0 mg/dL). Intravenous esmolol and nicardipine infusions are initiated, successfully lowering his blood pressure to 118/74 mmHg and heart rate to 62/min. A computed tomography angiography of the chest, abdomen, and pelvis demonstrates an intimal flap originating just distal to the left subclavian artery and extending into the common iliac arteries. The true lumen is severely compressed by the false lumen. The superior mesenteric and right renal arteries arise from the false lumen, which exhibits delayed and sluggish contrast enhancement. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Thoracic endovascular aortic repair and branch vessel stenting

Cevap

Thoracic endovascular aortic repair and branch vessel stenting
The correct answer involves performing a thoracic endovascular aortic repair (TEVAR) and branch vessel stenting. This patient has a Stanford Type B aortic dissection (originating distal to the left subclavian artery). While the initial management for Type B dissection is strict anti-impulse therapy (which was appropriately initiated), this patient's presentation is complicated by malperfusion syndrome. Malperfusion is evidenced by his diffuse abdominal pain with elevated lactate (mesenteric ischemia), acute acute kidney injury (renal ischemia), and a cool, pulseless right leg (limb ischemia). The CT scan confirms that the superior mesenteric and right renal arteries originate from the compromised false lumen. In the setting of complicated Type B dissection (malperfusion, rupture, rapid expansion, or refractory pain), emergent procedural intervention is required to open the true lumen and restore flow to the branch vessels. TEVAR has largely replaced open surgical repair in this setting due to significantly lower rates of mortality and perioperative complications, such as spinal cord ischemia.

Adım Adım Çözüm

1
Identify the primary diagnosis based on the clinical presentation and imaging.
The patient has an acute Type B aortic dissection, indicated by tearing back pain, severe hypertension, and an intimal flap originating distal to the left subclavian artery on CT angiography.
Accurate anatomical classification (Stanford Type A vs. Type B) dictates the overarching management algorithm.
2
Assess for complications indicating a deviation from standard medical therapy.
The patient exhibits malperfusion syndrome affecting the gut (abdominal pain, elevated lactate), kidneys (elevated creatinine), and right leg (absent pulses, cool extremity), caused by the false lumen compromising branch arteries.
Uncomplicated Type B dissections are managed medically. Complicated Type B dissections (rupture, malperfusion, rapid expansion, intractable pain) require emergent procedural intervention.
3
Select the most appropriate procedural intervention for complicated Type B aortic dissection.
Thoracic endovascular aortic repair (TEVAR) is selected.
Endovascular techniques can fenestrate the flap or stent the true lumen to restore distal perfusion with significantly lower morbidity and mortality compared to open descending aortic surgery.

Anahtar Kavram

Management of complicated Type B aortic dissection with malperfusion syndrome requires emergent endovascular intervention (TEVAR/stenting) rather than medical therapy alone.
Tahmini Süre:2m 0s
Soru 709Soru →

A 65-year-old woman schedules a telehealth consultation to establish primary care after moving to a new state. She reports feeling well and takes only a daily multivitamin. She underwent menopause at age 51. She has never used tobacco products, drinks alcohol occasionally, and walks two miles daily. Her family history is notable for hypertension in her father. She reports her last colonoscopy was at age 62 and was normal, and her last mammogram was six months ago and normal. Which of the following screening tests is most appropriate to order for this patient today?

Cevabı ve açıklamayı göster

Cevap: Dual-energy x-ray absorptiometry

Cevap

Dual-energy x-ray absorptiometry
The United States Preventive Services Task Force (USPSTF) recommends screening for osteoporosis with bone measurement testing (such as dual-energy x-ray absorptiometry) in women aged 65 years and older to prevent osteoporotic fractures. This patient has just reached the age milestone of 65 and requires this one-time baseline screening, regardless of her excellent health status and lack of specific clinical risk factors.

Adım Adım Çözüm

1
Identify the patient's demographic profile and active risk factors.
The patient is a 65-year-old female with no history of tobacco use and up-to-date breast and colon cancer screenings.
Preventive screening guidelines are heavily dependent on age, biological sex, and specific risk exposures (e.g., smoking).
2
Apply age-based United States Preventive Services Task Force (USPSTF) screening guidelines.
The USPSTF recommends routine screening for osteoporosis with bone measurement testing in all women aged 65 years and older.
Age 65 is the threshold where the risk of osteoporotic fractures in women justifies universal screening regardless of other clinical risk factors.
3
Select the appropriate diagnostic modality for the indicated screening.
Dual-energy x-ray absorptiometry (DEXA) is the gold standard and indicated test.
DEXA precisely measures bone mineral density at the hip and lumbar spine to diagnose osteoporosis.

Anahtar Kavram

The USPSTF recommends routine osteoporosis screening with bone measurement testing (e.g., dual-energy x-ray absorptiometry) for all women aged 65 years and older.
Soru 710Soru →

A psychiatrist is evaluating a 31-year-old male patient who recently experienced a severe acute manic episode. The physician decides to initiate pharmacotherapy with valproate as a mood stabilizer. Before starting this medication and periodically during the initial months of treatment, specific laboratory parameters must be monitored due to the drug's known adverse effect profile. Which of the following diagnostic studies should be routinely obtained for this patient? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Complete blood count; Hepatic function panel

Cevap

Complete blood count AND Hepatic function panel
Valproate is associated with two major, potentially severe adverse effects that require routine serologic monitoring: hepatotoxicity and dose-related hematologic abnormalities (most commonly thrombocytopenia). A baseline hepatic function panel is essential because valproate carries a black box warning for fatal hepatic failure. Similarly, a baseline complete blood count is necessary to establish a baseline platelet count and monitor for subsequent bone marrow suppression during dose titrations.

Adım Adım Çözüm

1
Identify the initiated medication and its class.
The medication is valproate, an antiepileptic drug commonly used as a mood stabilizer for bipolar disorder.
Understanding the specific drug is required to recall its unique adverse effect profile and safety guidelines.
2
Recall the major adverse effects associated with the identified medication.
Major toxicities of valproate include hepatotoxicity, thrombocytopenia, and neural tube defects (in pregnant patients).
Routine monitoring requirements are directly derived from the drug's most serious or common side effects.
3
Select the laboratory tests that screen for these specific adverse effects.
A hepatic function panel screens for hepatotoxicity, and a complete blood count screens for thrombocytopenia.
Baseline and ongoing evaluation of these serologic parameters ensures patient safety during pharmacotherapy.

Anahtar Kavram

Baseline and ongoing monitoring for valproate therapy requires a complete blood count (to assess for thrombocytopenia) and a hepatic function panel (to assess for hepatotoxicity).
Soru 711Soru →

A physician is reviewing the laboratory results of a 64-year-old woman who had blood drawn earlier in the day for routine monitoring. The patient has a history of rheumatic heart disease and underwent a mechanical mitral valve replacement four years ago. She is maintained on chronic warfarin therapy. Three days ago, she was evaluated at an urgent care clinic for dysuria and was prescribed a short course of trimethoprim-sulfamethoxazole. During a subsequent telephone encounter, the patient reports feeling well and denies any bruising, bleeding gums, epistaxis, or dark stools. Her target international normalized ratio (INR) is 2.5 to 3.5. Today, her INR is reported as 7.2. Which of the following is the most appropriate next step in the management of this patient's anticoagulation?

Cevabı ve açıklamayı göster

Cevap: Hold the warfarin, recheck the international normalized ratio in 24 to 48 hours, and resume at a lower dose

Cevap

Hold the warfarin, recheck the international normalized ratio in 24 to 48 hours, and resume at a lower dose
The patient presents with a supratherapeutic INR of 7.2, likely secondary to a pharmacokinetic drug interaction between her chronic warfarin therapy and a recently initiated course of trimethoprim-sulfamethoxazole. Trimethoprim-sulfamethoxazole inhibits the cytochrome P450 2C9 (CYP2C9) enzyme, reducing the metabolism of warfarin and prolonging its anticoagulant effect. According to current consensus guidelines for the management of supratherapeutic INR, if a patient's INR is between 4.5 and 10.0 and there is no evidence of bleeding, the most appropriate management is to withhold the next one to two doses of warfarin, monitor the INR closely, and resume therapy at a lower, adjusted dose once the INR returns to the therapeutic range. Routine administration of vitamin K (phytonadione) is not recommended in this scenario because it does not improve clinical outcomes and can unnecessarily complicate re-anticoagulation.

Adım Adım Çözüm

1
Identify the patient's clinical status and laboratory abnormality.
The patient is asymptomatic with no signs of bleeding, but has a supratherapeutic INR of 7.2.
Determining the presence or absence of active bleeding is the critical first step in triaging the urgency of anticoagulation reversal.
2
Determine the etiology of the abnormal laboratory finding.
The elevated INR is due to a pharmacokinetic drug-drug interaction between warfarin and the recently prescribed trimethoprim-sulfamethoxazole.
Trimethoprim-sulfamethoxazole is a potent inhibitor of CYP2C9, the primary enzyme responsible for metabolizing the more active S-enantiomer of warfarin, leading to rapid accumulation and increased bleeding risk.
3
Apply consensus guidelines for managing a supratherapeutic INR without bleeding.
The correct management for an INR between 4.5 and 10.0 without bleeding is to hold the next 1-2 doses of warfarin.
Routine use of vitamin K is not recommended in this specific range for asymptomatic patients, as it does not reduce the incidence of bleeding events but does make achieving therapeutic anticoagulation more difficult afterward.

Anahtar Kavram

Management of asymptomatic supratherapeutic INR (4.5 to 10.0) involves withholding warfarin doses without routine administration of vitamin K.
Soru 712Soru →

A 3838-year-old man presents to the clinic for a follow-up evaluation of worsening fatigue, a 6-kg6\text{-kg} (13.2-lb13.2\text{-lb}) weight gain, and easy bruising over the past 33 months. He also reports new-onset muscle weakness when climbing stairs. His medical history is significant for HIV, diagnosed 44 years ago, and severe seasonal allergic rhinitis. His current medications include a single-tablet antiretroviral regimen consisting of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide. Four months ago, he was prescribed a fluticasone nasal spray for his allergic rhinitis, which he uses twice daily.

Vital signs are temperature 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure 158/96 mmHg158/96 \text{ mmHg}, pulse 82/min82\text{/min}, and respirations 14/min14\text{/min}. BMI is 31 kg/m231 \text{ kg/m}^2. Physical examination reveals a plethoric face, prominent supraclavicular fat pads, and wide violaceous striae on the lower abdomen.

Laboratory studies:
Sodium: 142 mEq/L142 \text{ mEq/L}
Potassium: 3.8 mEq/L3.8 \text{ mEq/L}
Fasting glucose: 135 mg/dL135 \text{ mg/dL}
Morning serum cortisol: 1.2 \mug/dL1.2 \text{ \mu g/dL} (Normal: 6–23 \mug/dL6\text{--}23 \text{ \mu g/dL})
Plasma ACTH: <5 pg/mL< 5 \text{ pg/mL} (Normal: 10–60 pg/mL10\text{--}60 \text{ pg/mL})
HIV viral load: Undetectable
CD4 T-lymphocyte count: 620/mm3620\text{/mm}^3

What is the most appropriate next step in the pharmacologic management of this patient?

Cevabı ve açıklamayı göster

Cevap: Transition the antiretroviral therapy to a bictegravir-based regimen and initiate a glucocorticoid taper

Cevap

Transition the antiretroviral therapy to a bictegravir-based regimen and initiate a glucocorticoid taper
Cobicistat is a potent pharmacokinetic enhancer that strongly inhibits the cytochrome P450 3A4 (CYP3A4) enzyme. Fluticasone is a synthetic glucocorticoid that relies on extensive first-pass metabolism by CYP3A4. Concomitant administration prevents fluticasone clearance, leading to massive systemic accumulation. This causes iatrogenic Cushing syndrome and profound negative feedback on the hypothalamic-pituitary-adrenal (HPA) axis, evidenced by the suppressed ACTH and endogenous cortisol. The definitive management is to remove the CYP3A4 inhibitor by transitioning the patient to an effective antiretroviral regimen that does not require boosting, such as an unboosted integrase inhibitor (e.g., a bictegravir-based regimen). However, because the fluticasone will rapidly clear once the CYP3A4 inhibition is removed, and the patient's HPA axis remains suppressed, a systemic glucocorticoid taper must be initiated simultaneously to prevent an acute, life-threatening adrenal crisis.

Adım Adım Çözüm

1
Identify the clinical syndrome based on the physical exam and metabolic findings.
The patient's weight gain, plethora, striae, weakness, and hyperglycemia indicate Cushing syndrome.
Recognizing the phenotype is the first step in determining the underlying etiology.
2
Interpret the endocrinology laboratory results.
The low morning cortisol and profoundly suppressed ACTH confirm that the Cushing syndrome is iatrogenic (exogenous), caused by the fluticasone nasal spray.
Endogenous Cushing syndrome would present with elevated cortisol and either elevated (pituitary/ectopic) or suppressed (adrenal) ACTH. Suppressed values for both indicate exogenous glucocorticoid excess.
3
Identify the underlying pharmacokinetic drug interaction.
Cobicistat is a potent CYP3A4 inhibitor, which prevents the normal hepatic clearance of fluticasone (a CYP3A4 substrate), leading to massive systemic accumulation.
Fluticasone normally has low systemic bioavailability, but CYP3A4 inhibition drastically increases its systemic exposure, causing iatrogenic Cushing syndrome.
4
Determine the safest pharmacologic intervention.
The CYP3A4 inhibitor must be removed by switching to an unboosted HIV regimen (e.g., bictegravir). Simultaneously, a glucocorticoid taper must be initiated.
Removing the interaction will cause fluticasone levels to drop rapidly. Because the HPA axis is suppressed, failing to provide exogenous glucocorticoid coverage during this transition will precipitate a life-threatening adrenal crisis.

Anahtar Kavram

Management of pharmacokinetic interactions between potent CYP3A4 inhibitors (cobicistat/ritonavir) and CYP3A4 substrates (fluticasone), including mitigating the risk of adrenal crisis upon withdrawal.
Soru 713Soru →

A 48-year-old male construction worker visits a primary care clinic to establish care. He states that he feels entirely healthy and has avoided the medical system for over twenty years. He currently smokes one pack of cigarettes daily and has maintained this habit since his early twenties. He is in a monogamous relationship with a new female partner. Vital signs are within normal limits, and his body mass index is 23 kg/m². He has no family history of malignancy or premature cardiovascular disease. Based on current evidence-based guidelines, which of the following preventive screening tests should be ordered for this patient today? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Colorectal cancer screening via colonoscopy or stool-based testing; Routine screening for human immunodeficiency virus (HIV) infection; One-time screening for hepatitis C virus (HCV) infection

Cevap

The correct interventions are colorectal cancer screening, human immunodeficiency virus (HIV) screening, and hepatitis C virus (HCV) screening.
Based on current US Preventive Services Task Force (USPSTF) guidelines, adults aged 45 to 75 should undergo routine colorectal cancer screening. Furthermore, because this patient has had no medical care in over twenty years, he requires catch-up baseline screenings. The USPSTF recommends universal one-time screening for HIV in individuals aged 15 to 65, and one-time screening for HCV in adults aged 18 to 79. All three of these are strongly recommended (Grade A or B) and appropriately timed for a 48-year-old male.

Adım Adım Çözüm

1
Analyze the patient's demographic and historical profile.
The patient is a 48-year-old male with a 20+ pack-year smoking history, normal BMI, and no prior preventive medical care.
Preventive screening guidelines are strictly dependent on age, biological sex, and specific risk factors like smoking history.
2
Evaluate for indicated age-appropriate general screenings.
Colorectal cancer screening (starts at age 45), HIV screening (once for ages 15-65), and HCV screening (once for ages 18-79) are all indicated.
The patient has not been seen by a physician in over 20 years, meaning he has missed all universal one-time and age-based baseline screenings.
3
Evaluate for risk-specific screenings based on his smoking history.
He does not qualify for low-dose computed tomography (requires age 50-80) or abdominal aortic aneurysm screening (requires age 65-75).
Applying exact guideline age cutoffs prevents unnecessary testing and potential false positives in younger patients.

Anahtar Kavram

Application of age-specific and risk-specific USPSTF preventive screening guidelines in primary care.
Soru 714Soru →

A 49-year-old premenopausal female is evaluated in the medical oncology clinic to discuss adjuvant therapy following a recent lumpectomy and sentinel lymph node biopsy. Pathology demonstrated a 1.5-cm, estrogen receptor-positive, progesterone receptor-positive, and HER2-negative invasive ductal carcinoma. Margins were negative, and no lymph nodes were involved. She completed adjuvant radiation therapy last week and is now scheduled to begin endocrine therapy. Her past medical history includes major depressive disorder, which has been well-controlled on paroxetine for the past 4 years. She currently reports no depressive symptoms but complains of moderate daily hot flashes. Vital signs and physical examination are unremarkable. The oncologist plans to start tamoxifen. Which of the following is the most appropriate recommendation regarding this patient's pharmacotherapy?

Cevabı ve açıklamayı göster

Cevap: Discontinue paroxetine and initiate venlafaxine

Cevap

Discontinue paroxetine and initiate venlafaxine
The correct intervention is to discontinue paroxetine and initiate venlafaxine. Tamoxifen is a prodrug that is converted in the liver by the cytochrome P450 enzyme CYP2D6 into its highly active metabolite, endoxifen. Paroxetine is a potent inhibitor of CYP2D6. Concurrent administration of paroxetine and tamoxifen prevents this metabolic conversion, leading to subtherapeutic endoxifen levels and an increased risk of breast cancer recurrence. Therefore, paroxetine must be discontinued. Venlafaxine, a serotonin-norepinephrine reuptake inhibitor (SNRI), is a weak inhibitor of CYP2D6 that does not significantly affect tamoxifen metabolism. Furthermore, venlafaxine is an excellent choice for this patient because it effectively treats both major depressive disorder and vasomotor symptoms (hot flashes), which the patient is currently experiencing.

Adım Adım Çözüm

1
Identify the planned therapy and its mechanism of action.
The patient is scheduled to begin tamoxifen, a selective estrogen receptor modulator (SERM) that acts as a prodrug.
Understanding tamoxifen's metabolism is required to anticipate drug interactions.
2
Evaluate the patient's current medication list for pharmacokinetic interactions.
The patient is taking paroxetine. Tamoxifen requires activation by the hepatic enzyme CYP2D6 to its active metabolite, endoxifen. Paroxetine is a strong CYP2D6 inhibitor.
Concurrent use of strong CYP2D6 inhibitors prevents the formation of endoxifen, significantly reducing tamoxifen's efficacy and increasing the risk of breast cancer recurrence.
3
Determine the most appropriate pharmacologic adjustment.
Paroxetine must be discontinued. A safe alternative that does not inhibit CYP2D6, such as venlafaxine or escitalopram, should be initiated.
Venlafaxine will safely manage both the patient's major depressive disorder and her hot flashes without compromising the efficacy of tamoxifen.

Anahtar Kavram

Tamoxifen is a prodrug activated by CYP2D6; concurrent use of strong CYP2D6 inhibitors (e.g., paroxetine, fluoxetine) reduces its efficacy and should be avoided by switching to safe alternatives like venlafaxine or escitalopram.
Soru 715Soru →

Determine the most appropriate post-acute care disposition for each patient based on their clinical stability, functional status, and required level of ongoing medical intervention.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 55-year-old woman recovering from an ischemic stroke with right-sided hemiplegia; she is medically stable and capable of participating in 3.5 hours of intensive physical and occupational therapy daily.
A 62-year-old man with severe acute respiratory distress syndrome (ARDS); he remains ventilator-dependent on hospital day 21 and requires slow, prolonged respiratory weaning.
A 77-year-old man recovering from surgical fixation of a femoral neck fracture; he is significantly deconditioned, requires assistance with basic activities of daily living, and can tolerate a maximum of 45 minutes of physical therapy per day.
A 50-year-old woman with diabetic foot osteomyelitis who is hemodynamically stable, independently ambulatory, and requires a 6-week course of daily intravenous antibiotics and weekly wound care.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The stroke patient capable of 3.5 hours of therapy matches to an Inpatient Rehabilitation Facility (IRF). The ventilator-dependent ARDS patient matches to a Long-Term Acute Care Hospital (LTACH). The deconditioned hip fracture patient matches to a Skilled Nursing Facility (SNF). The stable osteomyelitis patient matches to Home with Home Health Agency services.
Appropriate care setting transitions rely on matching the patient's medical complexity and functional capacity with facility capabilities. LTACHs serve patients needing prolonged acute care (e.g., ventilator weaning). IRFs serve medically stable patients requiring intensive multidisciplinary rehab (at least 3 hours/day). SNFs are for patients needing daily skilled nursing or rehab who cannot tolerate IRF-level intensity. Home Health Agencies provide intermittent skilled care to stable patients in their homes.

Adım Adım Çözüm

1
Evaluate the patient's ongoing medical acuity and need for physician supervision.
The ventilator-dependent patient has the highest medical acuity, pointing toward an LTACH.
LTACHs are designed for medically complex patients requiring prolonged acute care, such as mechanical ventilation weaning.
2
Assess functional capacity and tolerance for rehabilitation.
The stroke patient can tolerate >3 hours of therapy, qualifying for an IRF. The hip fracture patient can only tolerate 45 minutes, qualifying for an SNF.
Medicare guidelines mandate that IRF patients must be able to participate in a minimum of 3 hours of intensive therapy daily; those who cannot must be directed to an SNF.
3
Determine if skilled care can be provided in the outpatient or home setting.
The osteomyelitis patient requires IV antibiotics but is otherwise stable and ambulatory.
Patients requiring intermittent skilled care (like IV infusions or wound care) who are otherwise stable should be managed at home with Home Health Agency support to minimize healthcare costs and nosocomial risks.

Anahtar Kavram

Criteria for Post-Acute Care Setting Transitions
Tahmini Süre:1m 30s
Soru 716Soru →

A 68-year-old man with a history of persistent atrial fibrillation presents to the emergency department complaining of sudden, severe pain in his right lower extremity that began two hours ago. On physical examination, the right leg is cold and pale distal to the knee. The patient exhibits diminished light touch sensation over the dorsum of the foot, but he can freely wiggle his toes and dorsiflex his ankle. Femoral pulses are strong bilaterally, but right popliteal and pedal pulses are nonpalpable. Handheld continuous-wave Doppler demonstrates absent arterial signals but present venous signals in the right foot. Arrange the following management steps in the most appropriate chronological sequence for this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for managing this patient's marginally threatened acute limb ischemia is: 1. Administer intravenous heparin, 2. Obtain a CTA of the lower extremity, 3. Perform definitive revascularization, 4. Monitor for compartment syndrome.
The correct sequence for managing Rutherford Category IIa acute limb ischemia begins with immediate systemic anticoagulation to halt thrombus propagation. Because the limb is marginally threatened (characterized by intact motor function and audible venous Doppler signals), there is time for advanced imaging (CTA) to delineate the anatomy and appropriately plan the procedure. This is followed by definitive revascularization (surgical embolectomy or catheter-directed thrombolysis). Finally, post-revascularization monitoring is essential due to the high risk of reperfusion-induced compartment syndrome, which may require a fasciotomy.

Adım Adım Çözüm

1
Administer an intravenous heparin bolus and continuous infusion
Prevents propagation of the existing thrombus and preserves collateral circulation.
Systemic anticoagulation is the most critical initial intervention for acute limb ischemia and must be started immediately upon clinical diagnosis, prior to imaging.
2
Obtain an urgent computed tomography angiography (CTA) of the lower extremity
Defines the level of the occlusion and maps the arterial anatomy.
Because the limb is marginally threatened (intact motor function, audible venous Doppler), there is time to obtain advanced imaging to plan the optimal revascularization strategy.
3
Perform definitive revascularization via surgical embolectomy or thrombolysis
Restores arterial perfusion to the ischemic limb.
After anatomic mapping, the obstructing embolus (likely from atrial fibrillation) must be removed or lysed to salvage the tissue.
4
Monitor closely for clinical signs of compartment syndrome
Ensures early detection of reperfusion injury.
Restoration of blood flow to ischemic tissue can cause capillary leak, muscle edema, and increased fascial compartment pressure, potentially requiring a fasciotomy.

Anahtar Kavram

The management of acute limb ischemia (ALI) involves immediate systemic anticoagulation followed by imaging (if the limb is marginally threatened) and definitive revascularization, with subsequent vigilance for reperfusion injury.
Tahmini Süre:1m 15s
Soru 717Soru →

A 74-year-old woman with a history of permanent atrial fibrillation and medication nonadherence presents to the emergency department with a 2-hour history of sudden, severe, mid-abdominal pain. She is writhing in agony, but her abdomen is surprisingly soft and non-tender to palpation. Vital signs show a heart rate of 118118/min, blood pressure of 142/88142/88 mmHg, and respiratory rate of 2222/min. Laboratory studies reveal a leukocyte count of 18,500/mm318,500/mm^3 and a serum lactate level of 4.24.2 mmol/L. She is suspected of having acute superior mesenteric artery embolism.

Arrange the following interventions in the most appropriate chronological sequence for the definitive management of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: 1) Intravenous fluid resuscitation and broad-spectrum antibiotics, 2) Computed tomography angiography of the abdomen and pelvis, 3) Initiation of systemic anticoagulation with intravenous heparin, 4) Exploratory laparotomy with surgical embolectomy, 5) Second-look laparotomy at 24 to 48 hours.
The management of acute mesenteric ischemia follows a strict sequential protocol. Initially, aggressive intravenous fluid resuscitation and broad-spectrum antibiotics are mandatory to treat hypovolemia from third-spacing and to cover translocating enteric flora. Once hemodynamically stable, computed tomography angiography (CTA) is the gold standard to definitively localize the occlusion. Upon confirmation of an arterial embolus, systemic anticoagulation with intravenous heparin is immediately initiated to prevent distal clot propagation. The patient is then taken for emergent exploratory laparotomy for surgical embolectomy and assessment of bowel viability. Because initial visual inspection of the bowel can be misleading, a planned second-look laparotomy at 24 to 48 hours is standard practice to ensure no further necrosis has occurred.

Adım Adım Çözüm

1
Administer aggressive intravenous fluid resuscitation and broad-spectrum antibiotics.
Restores intravascular volume lost to third-spacing and mitigates the risk of sepsis from bacterial translocation across the ischemic bowel wall.
Patients with mesenteric ischemia often present with significant dehydration and impending sepsis, making hemodynamic stabilization the critical first maneuver.
2
Obtain computed tomography angiography (CTA) of the abdomen and pelvis.
Confirms the clinical suspicion of superior mesenteric artery (SMA) embolism and precisely localizes the clot.
CTA is highly sensitive and specific for mesenteric vessel occlusion and dictates the surgical approach. It is indicated once the patient is sufficiently stabilized.
3
Initiate systemic anticoagulation with intravenous heparin.
Halts the coagulation cascade and prevents the existing clot from propagating further into the distal mesenteric arcades.
Distal propagation limits the effectiveness of surgical embolectomy and worsens bowel ischemia. Anticoagulation is standard immediately upon diagnosis unless there is active hemorrhage.
4
Perform exploratory laparotomy with surgical embolectomy.
Directly removes the embolus, restoring pulsatile blood flow to the SMA distribution, followed by resection of any frankly necrotic bowel.
Surgical revascularization is the definitive treatment for acute embolic mesenteric ischemia to prevent irreversible transmural bowel infarction.
5
Perform a planned second-look laparotomy in 24 to 48 hours.
Allows surgical re-evaluation of bowel segments that appeared marginally viable during the initial operation.
Initial intraoperative assessment of bowel viability can be notoriously inaccurate. A planned second look prevents the devastating complication of leaving necrotic bowel in the abdomen.

Anahtar Kavram

Surgical and procedural sequencing for acute mesenteric ischemia
Tahmini Süre:2m 0s
Soru 718Soru →

A 61-year-old woman is evaluated in the clinic after an emergency department visit two days ago for a minor mechanical fall. During that visit, a non-contrast CT scan of the abdomen and pelvis was performed to evaluate for suspected rib or solid organ injury. The scan showed no traumatic injuries, but an incidental 2.8-cm mass was identified in the left adrenal gland. The mass is well-circumscribed and homogeneous, with an attenuation of 4 Hounsfield units. The patient's medical history is significant for estrogen receptor-positive breast cancer treated with a lumpectomy and radiation therapy six years ago; she has been in remission since. She currently feels well and reports no abdominal pain, palpitations, headaches, or unexplained weight changes. Blood pressure is 126/82 mmHg, and heart rate is 72/min. Physical examination reveals no abdominal tenderness, striae, or palpable masses. Which of the following is the most appropriate next step in the diagnostic workup of this patient's adrenal mass?

Cevabı ve açıklamayı göster

Cevap: Measurement of plasma free metanephrines and an overnight 1-mg dexamethasone suppression test

Cevap

Measurement of plasma free metanephrines and an overnight 1-mg dexamethasone suppression test
The correct sequence for evaluating a newly discovered adrenal incidentaloma involves two distinct pathways: radiologic evaluation to assess malignancy risk and biochemical evaluation to assess functional status. Radiologically, this mass is well-circumscribed, homogeneous, and has an attenuation of <10 Hounsfield units (HU), which confidently identifies it as a benign, lipid-rich adenoma, effectively ruling out metastasis from her prior breast cancer. Despite the benign imaging appearance, all adrenal incidentalomas must be evaluated for subclinical hormone hypersecretion. The standard initial workup includes an overnight 1-mg dexamethasone suppression test (to screen for autonomous cortisol secretion) and measurement of plasma free metanephrines or 24-hour urine fractionated metanephrines (to screen for pheochromocytoma). Since her blood pressure is normal, screening for primary hyperaldosteronism with a plasma aldosterone-to-renin ratio is not indicated.

Adım Adım Çözüm

1
Analyze the imaging characteristics of the incidentaloma.
The mass is 2.8 cm, homogeneous, and has an attenuation of 4 Hounsfield units (HU).
HU < 10 is diagnostic of a lipid-rich, benign adrenal adenoma, which makes a metastasis from her prior breast cancer highly unlikely.
2
Determine the required evaluation for all newly discovered adrenal incidentalomas.
All patients require biochemical testing to evaluate for functional status, regardless of the presence or absence of symptoms.
Subclinical hormone secretion (especially cortisol and catecholamines) is common and alters management.
3
Select the appropriate biochemical screening tests.
Plasma free metanephrines (or 24-hour urine fractionated metanephrines) and a 1-mg overnight dexamethasone suppression test.
These tests screen for pheochromocytoma and autonomous cortisol secretion, respectively. (Aldosterone/renin screening is only indicated if the patient has hypertension or hypokalemia).

Anahtar Kavram

Diagnostic sequencing for adrenal incidentalomas requires biochemical evaluation for hormone hypersecretion in all patients prior to any invasive procedures, even when imaging suggests a benign etiology.
Soru 719Soru →

A 45-year-old woman is evaluated in the transplant clinic 3 months after receiving a deceased-donor renal allograft. Her maintenance immunosuppression regimen includes tacrolimus, mycophenolate mofetil, and prednisone. Routine surveillance laboratory testing reveals a new quantitative cytomegalovirus (CMV) DNA viral load of 15,000 IU/mL15,000 \text{ IU/mL}. She is currently asymptomatic and her renal allograft function is stable. The decision is made to manage this active CMV infection to prevent progression to tissue-invasive disease.

Arrange the following steps in the correct chronological sequence for the therapeutic management, monitoring, and evaluation of this patient's CMV infection.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with initiating oral valganciclovir, followed by weekly monitoring of the viral load and CBC. If the viral load does not decline after 14 days, genotypic resistance testing is ordered. If resistance is confirmed, therapy is switched to maribavir or foscarnet. Finally, the effective therapy is continued until the virus is undetectable.
The standard algorithm for monitoring and evaluating CMV treatment in a transplant recipient begins with initiating first-line therapy (valganciclovir). Efficacy and toxicity are monitored via weekly viral loads and complete blood counts. If the viral load is refractory after a sufficient therapeutic trial (at least 2 weeks), genotypic testing is indicated to look for UL97 or UL54 mutations. If resistance is confirmed, switching to maribavir or foscarnet is the standard next step. Regardless of whether the patient responds to the first or second-line agent, induction therapy must be continued until the viral load is proven undetectable on consecutive weekly tests.

Adım Adım Çözüm

1
Initiate induction-dose antiviral therapy with oral valganciclovir.
The patient begins standard first-line therapy for active CMV infection.
Oral valganciclovir is highly bioavailable and equivalent to intravenous ganciclovir for asymptomatic CMV viremia in solid organ transplant recipients.
2
Perform weekly surveillance of quantitative CMV DNA viral load and complete blood counts.
Treatment response and potential drug-induced toxicities are systematically monitored.
Weekly viral loads objectively assess the efficacy of treatment. CBC monitoring is essential due to the high risk of valganciclovir-induced myelosuppression.
3
Order genotypic resistance testing for viral mutations if the viral load fails to decline after two weeks.
Refractory CMV infection is identified and formally evaluated for antiviral resistance.
A lack of virologic response after 14 days of properly dosed therapy raises the suspicion for resistance mutations, necessitating genotypic analysis before arbitrarily changing medications.
4
Transition the antiviral regimen to oral maribavir or intravenous foscarnet if clinically significant resistance is confirmed.
The patient is placed on an effective second-line therapy.
Maribavir and foscarnet are effective for ganciclovir-resistant CMV isolates because their mechanisms of action bypass the viral UL97 kinase mutation.
5
Maintain the effective antiviral regimen until consecutive assays demonstrate an undetectable viral load.
The active CMV infection is successfully cleared.
Induction therapy duration is strictly guided by virologic endpoints, requiring consecutive weekly negative assays to confirm clearance before stopping treatment or transitioning to secondary prophylaxis.

Anahtar Kavram

The chronological management of CMV viremia in solid organ transplant recipients requires initiating valganciclovir, weekly virologic monitoring, resistance testing if treatment fails at two weeks, appropriate therapy transition for confirmed resistance, and continuation of treatment until complete virologic clearance.
Soru 720Soru →

A 67-year-old female is evaluated for transition of care from the medical intensive care unit. She was admitted 22 days ago for severe acute respiratory distress syndrome secondary to a viral pneumonitis. Her hospital course was complicated by ventilator-associated pneumonia and critical illness polyneuropathy. She was successfully extubated 4 days ago and is now breathing comfortably on 2 L/min of oxygen via nasal cannula.

Current medications include prophylactic enoxaparin, pantoprazole, and intravenous ceftriaxone (day 7 of a 14-day course for Pseudomonas pneumonia). She is receiving enteral nutrition via a newly placed percutaneous endoscopic gastrostomy (PEG) tube due to severe post-extubation dysphagia.

Vital signs are temperature 37.1 C (98.8 F), blood pressure 118/76 mm Hg, heart rate 82/min, and respiratory rate 16/min.

On examination, the patient is alert, oriented, and highly motivated to recover. She has a resolving 2 cm x 2 cm stage 2 pressure ulcer on her sacrum. Neurologic examination reveals symmetric 3/5 strength in the proximal upper and lower extremities. She requires maximal assistance to sit on the edge of the bed and cannot bear weight. Physical therapy notes indicate that she participates enthusiastically but experiences severe fatigue after 30 minutes of exertion and requires the remainder of the day to rest. She lives with her 72-year-old husband in a single-story home.

Which of the following is the most appropriate discharge disposition for this patient?

Cevabı ve açıklamayı göster

Cevap: Skilled nursing facility

Cevap

The most appropriate disposition is a skilled nursing facility, as the patient requires skilled medical care (IV antibiotics, PEG tube) and rehabilitation, but cannot tolerate the 3 hours of daily therapy required for an inpatient rehabilitation facility.
This patient has critical illness polyneuropathy and requires ongoing skilled medical care (IV antibiotics, PEG tube feeding, stage 2 wound care) as well as physical therapy. However, she cannot currently tolerate the intensive physical therapy required for admission to an inpatient rehabilitation facility (IRF). A skilled nursing facility (SNF) is the ideal setting, as it provides daily skilled nursing care without requiring daily physician oversight (unlike an LTACH) and offers subacute rehabilitation (typically 1-2 hours a day) to help patients build endurance until they can safely transition home or to an IRF.

Adım Adım Çözüm

1
Assess the patient's ongoing medical needs.
The patient is hemodynamically stable and extubated, but requires completion of IV antibiotics, PEG tube enteral feeding management, and routine stage 2 wound care.
Determining medical complexity differentiates between LTACH (needs daily physician care/vent weaning) and lower levels of care (SNF/Home).
2
Evaluate the patient's functional status and rehabilitation capacity.
The patient has severe ICU-acquired weakness, is max assist for mobility, and can only tolerate 30 minutes of physical therapy per day.
Functional capacity and therapy tolerance explicitly differentiate an Inpatient Rehabilitation Facility (>3 hours/day required) from a Skilled Nursing Facility (<3 hours/day).
3
Evaluate the safety of the home environment.
The patient requires maximal physical assistance which a 72-year-old spouse cannot safely provide.
Determines if discharge home with home health services is a safe and viable option.
4
Synthesize the data to select the appropriate facility.
The patient needs inpatient skilled nursing (for IV meds and PEG) and subacute physical therapy (since she cannot tolerate IRF levels), making a Skilled Nursing Facility (SNF) the correct choice.
SNFs bridge the gap for patients requiring daily nursing care and slow-paced rehabilitation.

Anahtar Kavram

Patients recovering from critical illness who require daily skilled nursing care (e.g., IV antibiotics, tube feedings) and rehabilitation, but cannot tolerate 3 hours of intensive daily therapy, should be discharged to a Skilled Nursing Facility (SNF) rather than an Inpatient Rehabilitation Facility (IRF) or Long-Term Acute Care Hospital (LTACH).
ÖncekiSayfa 36 / 104Sonraki